F. Mccutchan

发表

HIV-1 Nomenclature Proposal

G. Learn, B. Korber, P. Sharp, 2000, Science.

Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes.

J. Mullins, D. Burke, F. Mccutchan, 1994, AIDS research and human retroviruses.

Optimal Localization by Pointing Off Axis

Margaret L. Brandeau, Richard A. Olshen, Charles J. Stone, 2010 .

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

F. Mccutchan, N. Michael, F. Wabwire-mangen, 2009, Tissue antigens.

Implications of genetic variability in HIV for epidemiology and public health

R. Anderson, F. Mccutchan, B. Schwartländer, 1996, The Lancet.

Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.

E. G. Shpaer, J. Mullins, E. Delwart, 1993, Science.

Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction.

J. Mascola, F. Mccutchan, M. Salminen, 2000, Virology.

HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster.

F. Mccutchan, M. Robb, N. Michael, 2009, Tissue antigens.

S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

F. Mccutchan, M. Hoelscher, L. Maboko, 2009, Retrovirology.

HIV-1 nomenclature proposal: a reference guide to HIV-1 classification.

David L. Robertson, Feng Gao, Brian T. Foley, 2000 .

Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: associations of risk with genetic complexity.

F. Mccutchan, E. Sanders-Buell, M. Robb, 2011, Drug and alcohol dependence.

Complex mosaic structure of the partial envelope sequence from a Gambian HIV type 1 isolate.

H. Whittle, F. Mccutchan, M. Salminen, 1996, AIDS research and human retroviruses.

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization.

P. Sharp, D. Robertson, B. Hahn, 1994, AIDS research and human retroviruses.

Approaches to the development of broadly protective HIV vaccines: challenges posed by the genetic, biological and antigenic variability of HIV-1: Report* from a meeting of the WHO-UNAIDS Vaccine Advisory Committee** Geneva, 21–23 February 2000

Guido Ferrari, N. Nathanson, Donald S. Burke, 2001, AIDS.